TXNL1 and intermediate coronary syndrome: Cardiovascular events occurred in 47 patients (7.7%) of the TXL group and in 80 patients (13.2%) of the placebo group, (P = 0.002), and in particular, the occurrence of unstable angina pectoris was lower in the TXL than placebo group (P = 0.005) (Fig. 4, Supplementary Appendix IX: Table S1).